The largest database of trusted experimental protocols

Scrambled control shrna

Manufactured by GenePharma
Sourced in China

Scrambled control shRNA is a laboratory tool used to evaluate the efficacy of small hairpin RNA (shRNA) knockdown experiments. It serves as a negative control, providing a non-targeting shRNA sequence that does not affect the expression of any known genes. This allows researchers to distinguish the effects of their targeted shRNA from any non-specific or off-target effects.

Automatically generated - may contain errors

4 protocols using scrambled control shrna

1

Ectopic YAP Expression in HUVECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Full‐length human YAP ectopic expression lentivirus vector and the negative control (GeneChem, Shanghai, China) were transfected into HUVECs according to the manufacturer's instruction. YAP shRNA (5′‐CCCAGTTAAATGTTCACCAAT‐3′) and scrambled control shRNA (GenePharma, Shanghai, China) were transfected into HUVECs with the PolyJet DNA in vitro transfection reagent (SignaGen, Ijamsville, MD, USA).
+ Open protocol
+ Expand
2

SPAG6 Knockdown and Overexpression in Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
SPAG6 shRNA and scrambled control-shRNA were purchased from Shanghai GenePharma Company. For shRNA transfection, 293T cells were grown to 30–50% confluence in 6-well culture plates and transfected with scrambled shRNA or SPAG6 shRNA using Lipofectamine™ LTX reagent with PLUS™ reagent (Invitrogen; Thermo Fisher Scientific, Inc.) for 48 h. Then, the supernatant from 293T cells was harvested and added to Daudi and Raji cells for 72 h, followed by selection with 1 µg/ml puromycin for 1 month. Plasmids (pcDNA3.1-SPAG6 and pcDNA3.1) were purchased from Obio Technology Co., Ltd. For plasmid transfection, CA46 and NAMALWA cells (70% confluence) were plated in 6-well culture plates. Plasmids were purified and transfected with pcDNA3.1-SPAG6 or pcDNA3.1 for 72 h using Lipofectamine™ LTX reagent with PLUS™ reagent (Invitrogen; Thermo Fisher Scientific, Inc.), followed by selection with 1 µg/ml puromycin for 1 month.
+ Open protocol
+ Expand
3

PRDX2 Knockdown and Overexpression in Lung Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PRDX2 shRNAs and scrambled control shRNA were purchased from GenePharma Company (Shanghai, China). Using a Lipofectamine 2000 (Invitrogen)-based transfection method, A549 cells were transfected with PRDX2 shRNAs or scrambled control shRNA and selected with puromycin for 3-4 weeks. Specifically, 293T cells (30% confluence) were cultured in 6-well plates and transfected with PRDX2 shRNAs and scrambled control shRNA for 48 hours. Then, the medium from 293T cells was collected and was added to A549 cells (30%-50% confluence) for 48 h, followed by selection with 6 μg/ml puromycin for 3-4 weeks. Plasmids (pcDNA3.1-PRDX2 and pcDNA3.1) were obtained from OBiO Technology Co. Ltd. (Shanghai, China). NCI-H1299 cells (70% confluence) were cultured in 6-well plates and transfected with pcDNA3.1-PRDX2 or pcDNA3.1 for 72 hours using Lipofectamine 2000.
+ Open protocol
+ Expand
4

Silencing YAP1 and HIF-1α in Pancreatic Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
The YAP1 short hairpin RNA (shRNA; 5′-CCCAGTT AAATGTTCACCAAT-3′) and scrambled control shRNA (GenePharma, China) were transfected into PANC-1 and BxPC-3 cells. The HIF-1α expression was suppressed by shRNA interference (Santa Cruz Biotechnology), and plasmid-A shRNA (Santa Cruz Biotechnology) was used as a negative control. The cells were selected by 1 mg/mL of G418 or 1 µg/mL of puromycin for 2 weeks to form stable clones after transfection in vitro with PolyJet™ DNA transfection reagent (SignaGen Laboratories, USA) according to the manufacturer's protocol.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!